ReCor Medical Announces Successful First-in-human Clinical Case Using Ultrasound to Cure Mitral Regurgitation (MR)
9/22/2010 11:26:30 AM
RONKONKOMA, N.Y. & PARIS--(BUSINESS WIRE)--Ultrasound heart valve therapy company ReCor Medical announced today the successful completion of a first-in-human procedure using its ultrasound therapy to treat mitral regurgitation (MR). The study data will be presented today at the Transcatheter Cardiovascular Therapeutics (“TCT”) scientific meeting in Washington, D.C.
comments powered by